Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 129,502,142
- Share change
- +4,995,415
- Total reported value
- $2,475,760,428
- Put/Call ratio
- 224%
- Price per share
- $19.12
- Number of holders
- 239
- Value change
- +$40,167,326
- Number of buys
- 140
- Number of sells
- 122
Quarterly Holders Quick Answers
What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30050B101:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
10,915,070
|
$357,905,145 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
9.4%
|
10,592,234
|
$347,319,354 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.9%
|
8,853,631
|
$290,310,560 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.4%
|
8,295,382
|
$272,005,576 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.1%
|
5,736,132
|
$188,087,768 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.2%
|
4,747,107
|
$155,657,640 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
3.6%
|
3,987,500
|
$130,750,125 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.3%
|
3,717,667
|
$121,902,301 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
2.9%
|
3,269,219
|
$107,197,691 | — | 31 Mar 2024 | |
| Engaged Capital LLC |
13F
|
Company |
2.9%
|
3,261,458
|
$106,943,208 | — | 31 Mar 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.8%
|
3,191,303
|
$104,642,825 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,642,568
|
$86,649,805 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
2,605,615
|
$85,438,116 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,519,649
|
$82,619,291 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
2.2%
|
2,505,464
|
$82,154,165 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,469,862
|
$80,999,295 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
2,246,485
|
$73,662,243 | — | 31 Mar 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
2%
|
2,207,037
|
$72,368,743 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.9%
|
2,111,115
|
$69,224,000 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
1,958,462
|
$64,217,969 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
1,943,385
|
$63,723,594 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
1,641,504
|
$53,824,915 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.4%
|
1,560,144
|
$51,157,147 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.3%
|
1,483,096
|
$48,630,718 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,454,873
|
$47,705,286 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.3%
|
1,444,064
|
$47,350,858 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
1,395,247
|
$45,750,149 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
1,256,406
|
$41,197,553 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,200,798
|
$39,374,167 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1%
|
1,145,440
|
$37,559,000 | — | 31 Mar 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.94%
|
1,052,519
|
$34,512,090 | — | 31 Mar 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.92%
|
1,037,331
|
$34,014,083 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.83%
|
936,863
|
$30,719,738 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.69%
|
774,552
|
$24,731,445 | — | 31 Mar 2024 | |
| Frank J. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
903,126
mixed-class rows
|
$24,140,121 | — | 01 Jun 2023 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.65%
|
734,486
|
$24,083,796 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.64%
|
717,334
|
$23,522,000 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
0.6%
|
679,172
|
$22,270,050 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
673,386
|
$22,080,327 | — | 31 Mar 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.57%
|
638,500
|
$20,936,415 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
588,600
|
$19,300,217 | — | 31 Mar 2024 | |
| Summit Creek Advisors LLC |
13F
|
Company |
0.51%
|
573,768
|
$18,813,853 | — | 31 Mar 2024 | |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC |
13F
|
Company |
0.5%
|
565,625
|
$18,546,844 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.49%
|
553,465
|
$18,148,118 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.48%
|
543,203
|
$17,811,626 | — | 31 Mar 2024 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.45%
|
500,990
|
$16,427,461 | — | 31 Mar 2024 | |
| Hodges Capital Management Inc. |
13F
|
Company |
0.42%
|
474,746
|
$15,567,000 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.38%
|
428,736
|
$14,058,254 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.38%
|
421,419
|
$13,818,329 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
403,195
|
$13,220,764 | — | 31 Mar 2024 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2024
As of 30 Jun 2024,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
239 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,502,142 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., FMR LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, JPMORGAN CHASE & CO, Engaged Capital LLC, Rock Springs Capital Management LP, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
239
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
247
Q2 2024 holders
239
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.